Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
2.Cho HJ, Myung JK, Kim H et al (2015) Primary diffuse leptomeningeal glioneuronal tumors. Brain Tumor Pathol 32:49–55. https://doi.org/10.1007/s10014-014-0187-z
3.Choi E, Kim SI, Won JK et al (2019) Clinicopathological and molecular analysis of multinodular and vacuolating neuronal tumors of the cerebrum. Hum Pathol 86:203–212. https://doi.org/10.1016/j.humpath.2018.11.028
CAS Article PubMed Google Scholar
4.Komori T (2021) The molecular framework of pediatric-type diffuse gliomas: shifting toward the revision of the WHO classification of tumors of the central nervous system. Brain Tumor Pathol 38:1–3. https://doi.org/10.1007/s10014-020-00392-w
5.de Blank P, Fouladi M, Huse JT (2020) Molecular markers and targeted therapy in pediatric low-grade glioma. J Neurooncol 150:5–15. https://doi.org/10.1007/s11060-020-03529-1
6.Saez-Alegre M, Saceda Gutierrez JM, Utrilla Contreras C et al (2021) Diffuse leptomeningeal glioneuronal tumour: where to biopsy? Case report and literature review. Childs Nerv Syst 37:2405–2408. https://doi.org/10.1007/s00381-020-04955-2
7.Perez E, Capper D (2020) Invited Review: DNA methylation-based classification of paediatric brain tumours. Neuropathol Appl Neurobiol 46:28–47. https://doi.org/10.1111/nan.12598
CAS Article PubMed Google Scholar
8.Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000
CAS Article PubMed PubMed Central Google Scholar
9.Kurozumi K, Nakano Y, Ishida J et al (2019) High-grade glioneuronal tumor with an ARHGEF2-NTRK1 fusion gene. Brain Tumor Pathol 36:121–128. https://doi.org/10.1007/s10014-019-00345-y
CAS Article PubMed Google Scholar
10.Siegfried A, Rousseau A, Maurage CA et al (2019) EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity. Brain Pathol 29:53–62. https://doi.org/10.1111/bpa.12619
CAS Article PubMed Google Scholar
11.Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
CAS Article PubMed Google Scholar
12.Louis DN, Wesseling P, Aldape K et al (2020) cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol 30:844–856. https://doi.org/10.1111/bpa.12832
Article PubMed PubMed Central Google Scholar
13.Deng MY, Sill M, Sturm D et al (2020) Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC)—a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. Neuropathol Appl Neurobiol 46:422–430. https://doi.org/10.1111/nan.12590
CAS Article PubMed Google Scholar
14.Pickles JC, Mankad K, Aizpurua M et al (2021) A case series of diffuse glioneuronal tumours with oligodendroglioma-like features and nuclear clusters (DGONC). Neuropathol Appl Neurobiol 47:464–467. https://doi.org/10.1111/nan.12680
Article PubMed PubMed Central Google Scholar
15.Lee Y, Koh J, Kim SI et al (2017) The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta Neuropathol Commun 5:62. https://doi.org/10.1186/s40478-017-0465-1
CAS Article PubMed PubMed Central Google Scholar
16.Lim KY, Won JK, Park CK et al (2021) H3 G34-mutant high-grade glioma. Brain Tumor Pathol 38:4–13. https://doi.org/10.1007/s10014-020-00378-8
CAS Article PubMed Google Scholar
17.Gardiman MP, Fassan M, Orvieto E et al (2010) Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol 20:361–366. https://doi.org/10.1111/j.1750-3639.2009.00285.x
18.Deng MY, Sill M, Chiang J et al (2018) Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathol 136:239–253. https://doi.org/10.1007/s00401-018-1865-4
CAS Article PubMed Google Scholar
19.Beck DJK, Russel DS (1942) Oligodendrogliomatosis of the cerebrospinal pathway. Brain 65:352–372. https://doi.org/10.1093/brain/65.4.352
20.Yamamoto T, Komori T, Shibata N et al (1996) Multifocal neurocytoma/gangliocytoma with extensive leptomeningeal dissemination in the brain and spinal cord. Am J Surg Pathol 20:363–370. https://doi.org/10.1097/00000478-199603000-00014
CAS Article PubMed Google Scholar
21.Lakhani DA, Mankad K, Chhabda S et al (2020) Diffuse leptomeningeal glioneuronal tumor of childhood. AJNR Am J Neuroradiol 41:2155–2159. https://doi.org/10.3174/ajnr.A6737
CAS Article PubMed PubMed Central Google Scholar
22.Abongwa C, Cotter J, Tamrazi B et al (2020) Primary diffuse leptomeningeal glioneuronal tumors of the central nervous system: report of three cases and review of literature. Pediatr Hematol Oncol 37:248–258. https://doi.org/10.1080/08880018.2019.1711270
23.Rodriguez FJ, Perry A, Rosenblum MK et al (2012) Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 124:627–641. https://doi.org/10.1007/s00401-012-1037-x
24.Dodgshun AJ, SantaCruz N, Hwang J et al (2016) Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation. J Neurooncol 128:293–302. https://doi.org/10.1007/s11060-016-2109-x
CAS Article PubMed Google Scholar
25.Kang JH, Buckley AF, Nagpal S et al (2018) A diffuse leptomeningeal glioneuronal tumor without diffuse leptomeningeal involvement: detailed molecular and clinical characterization. J Neuropathol Exp Neurol 77:751–756. https://doi.org/10.1093/jnen/nly053
26.Lyle MR, Dolia JN, Fratkin J et al (2015) Newly identified characteristics and suggestions for diagnosis and treatment of diffuse leptomeningeal glioneuronal/neuroepithelial tumors: a case report and review of the literature. Child Neurol Open 2:1-7. https://doi.org/10.1177/2329048X14567531
27.Tiwari S, Yadav T, Pamnani J et al (2020) Diffuse leptomeningeal glioneuronal tumor: a unique leptomeningeal tumor entity. World Neurosurg 135:297–300. https://doi.org/10.1016/j.wneu.2019.12.119
28.Lee JK, Ko HC, Choi JG et al (2018) A case of diffuse leptomeningeal glioneuronal tumor misdiagnosed as chronic tuberculous meningitis without brain biopsy. Case Rep Neurol Med 2018:1391943. https://doi.org/10.1155/2018/1391943
Article PubMed PubMed Central Google Scholar
29.Yamasaki T, Sakai N, Shinmura K et al (2018) Anaplastic changes of diffuse leptomeningeal glioneuronal tumor with polar spongioblastoma pattern. Brain Tumor Pathol 35:209–216. https://doi.org/10.1007/s10014-018-0326-z
30.Schwetye KE, Kansagra AP, McEachern J et al (2017) Unusual high-grade features in pediatric diffuse leptomeningeal glioneuronal tumor: comparison with a typical low-grade example. Hum Pathol 70:105–112. https://doi.org/10.1016/j.humpath.2017.06.004
31.Aguilera D, Castellino RC, Janss A et al (2018) Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy. Childs Nerv Syst 34:329–334. https://doi.org/10.1007/s00381-017-3584-x
32.Lin A, Rodriguez FJ, Karajannis MA et al (2012) BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol 71:66–72. https://doi.org/10.1097/NEN.0b013e31823f2cb0
CAS Article PubMed Google Scholar
33.Rodriguez FJ, Schniederjan MJ, Nicolaides T et al (2015) High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 129:609–610. https://doi.org/10.1007/s00401-015-1400-9
Article PubMed PubMed Central Google Scholar
34.Chiang JCH, Harreld JH, Orr BA et al (2017) Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination. Acta Neuropathol 134:159–162. https://doi.org/10.1007/s00401-017-1728-4
CAS Article PubMed PubMed Central Google Scholar
35.Kumar A, Pathak P, Purkait S et al (2015) Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas. Cancer Genet 208:91–95. https://doi.org/10.1016/j.cancergen.2015.01.009
CAS Article PubMed Google Scholar
36.Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397–405. https://doi.org/10.1007/s00401-011-0802-6
CAS Article PubMed Google Scholar
37.Hawkins C, Walker E, Mohamed N et al (2011) BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma. Clin Cancer Res 17:4790–4798. https://doi.org/10.1158/1078-0432.CCR-11-0034
CAS Article PubMed Google Scholar
38.Chiang J, Dalton J, Upadhyaya SA et al (2019) Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion. Acta Neuropathol 137:179–181. https://doi.org/10.1007/s00401-018-1940-x
39.Manoharan N, Ajuyah P, Senapati A et al (2021) Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic a
留言 (0)